Self-reported health and smoking status, and body mass index: a case-control comparison based on GEN SCRIP (GENetics of SChizophRenia In Pakistan) data

Introduction Individuals with schizophrenia are at a high risk of physical health comorbidities and premature mortality. Cardiovascular and metabolic causes are an important contributor. There are gaps in monitoring, documenting and managing these physical health comorbidities. Because of their condition, patients themselves may not be aware of these comorbidities and may not be able to follow a lifestyle that prevents and manages the complications. In many low-income and middle-income countries including Pakistan, the bulk of the burden of care for those struggling with schizophrenia falls on the families. Objectives To determine the rate of self-reported physical health disorders and risk factors, like body mass index (BMI) and smoking, associated with cardiovascular and metabolic disorders in cases of schizophrenia compared with a group of mentally healthy controls. Design A case-controlled, cross-sectional multicentre study of patients with schizophrenia in Pakistan. Settings Multiple data collection sites across the country for patients, that is, public and private psychiatric OPDs (out patient departments), specialised psychiatric care facilities, and psychiatric wards of teaching and district level hospitals. Healthy controls were enrolled from the community. Participants We report a total of 6838 participants’ data with (N 3411 (49.9%)) cases of schizophrenia compared with a group of healthy controls (N 3427 (50.1%)). Results BMI (OR 0.98 (CI 0.97 to 0.99), p=0.0025), and the rate of smoking is higher in patients with schizophrenia than in controls. Problems with vision (OR 0.13 (0.08 to 0.2), joint pain (OR 0.18 (0.07 to 0.44)) and high cholesterol (OR 0.13 (0.05 to 0.35)) have higher reported prevalence in controls. The cases describe more physical health disorders in the category ‘other’ (OR 4.65 (3.01 to 7.18)). This captures residual disorders not listed in the questionnaire. Conclusions Participants with schizophrenia in comparison with controls report more disorders. The access in the ‘other’ category may be a reflection of undiagnosed disorders.

[1]  A. Carvalho,et al.  The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. , 2019, The lancet. Psychiatry.

[2]  S. Anthony Focus on eye care in schizophrenia , 2019, Clinical & experimental optometry.

[3]  Vasiliki Mamakou,et al.  Schizophrenia and type 2 diabetes mellitus. , 2018, Psychiatrike = Psychiatriki.

[4]  B. Hallahan,et al.  Reasons associated with treatment non-adherence in schizophrenia in a Pakistan cohort. , 2017, Asian journal of psychiatry.

[5]  G. Lewis,et al.  Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden , 2017, The lancet. Psychiatry.

[6]  Bhushan Chaudhari,et al.  Evaluation of treatment adherence in outpatients with schizophrenia , 2017, Industrial psychiatry journal.

[7]  J. McGrath,et al.  Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. , 2017, The lancet. Psychiatry.

[8]  A. Carvalho,et al.  Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries , 2016, BMC Medicine.

[9]  E. Severance,et al.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling , 2016, Schizophrenia Research.

[10]  S. Ganesh,et al.  Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies. , 2016, Asian journal of psychiatry.

[11]  E. Severance,et al.  Gastroenterology Issues in Schizophrenia: Why the Gut Matters , 2015, Current Psychiatry Reports.

[12]  M. Gallagher,et al.  Disease Burden Among Individuals with Severe Mental Illness in a Community Setting , 2016, Community Mental Health Journal.

[13]  P. Tseng,et al.  Bone Mineral Density in Schizophrenia , 2015, Medicine.

[14]  D. Vancampfort,et al.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis , 2015, World psychiatry : official journal of the World Psychiatric Association.

[15]  D. Vancampfort,et al.  Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management , 2015, Acta psychiatrica Scandinavica.

[16]  D. Hodge,et al.  Prevalence of Mental Health Illness among Patients with Adult-Onset Strabismus , 2015, Strabismus.

[17]  S. Silverstein,et al.  Schizophrenia and the eye , 2015, Schizophrenia Research: Cognition.

[18]  G. Breen,et al.  The relationship between schizophrenia and rheumatoid arthritis revisited: Genetic and epidemiological analyses , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[19]  M. Prince,et al.  Excess mortality in severe mental illness: 10-year population-based cohort study in rural Ethiopia , 2015, British Journal of Psychiatry.

[20]  D. Vancampfort,et al.  The prevalence and moderators of clinical pain in people with schizophrenia: A systematic review and large scale meta-analysis , 2014, Schizophrenia Research.

[21]  C. M. P. K. Reddy,et al.  Attitudes toward Medication and Reasons for Non-Compliance in Patients with Schizophrenia , 2014, Indian journal of psychological medicine.

[22]  T. Bradshaw,et al.  Obesity and Serious Mental Ill Health: A Critical Review of the Literature , 2014, Healthcare.

[23]  M. Davidson,et al.  Longitudinal association between epilepsy and schizophrenia:A population-based study , 2014, Epilepsy & Behavior.

[24]  Mary Cannon,et al.  The prevalence of psychosis in epilepsy; a systematic review and meta-analysis , 2014, BMC Psychiatry.

[25]  S. Mccarroll,et al.  The genomic psychiatry cohort: Partners in discovery , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[26]  K. Hancock,et al.  The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers , 2013, BMJ.

[27]  B. Guthrie,et al.  Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study , 2013, BMJ Open.

[28]  Marilyn A Winkleby,et al.  Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. , 2013, The American journal of psychiatry.

[29]  A. Mitchell,et al.  Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis , 2012, British Journal of Psychiatry.

[30]  R. Yolken,et al.  Toxoplasma gondii and other risk factors for schizophrenia: an update. , 2012, Schizophrenia bulletin.

[31]  M. Large,et al.  Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. , 2012, The Journal of clinical psychiatry.

[32]  M. Goldacre,et al.  Coexistence of schizophrenia and epilepsy: Record‐linkage studies , 2012, Epilepsia.

[33]  J. Pais,et al.  The Epidemiology of Excess Mortality in People with Mental Illness , 2010, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[34]  S. Kisely,et al.  Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare , 2009, British Journal of Psychiatry.

[35]  A. Fagiolini,et al.  The effects of undertreated chronic medical illnesses in patients with severe mental disorders. , 2009, The Journal of clinical psychiatry.

[36]  A. Mitchell,et al.  Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies , 2009, British Journal of Psychiatry.

[37]  Stefan Van der Stigchel,et al.  A review on eye movement studies in childhood and adolescent psychiatry , 2008, Brain and Cognition.

[38]  P. Dazzan,et al.  Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review , 2008, Psychological Medicine.

[39]  D. Mrazek,et al.  Mental Illness in Young Adults Who Had Strabismus as Children , 2008, Pediatrics.

[40]  Serge Marchand,et al.  Hypoalgesia in schizophrenia is independent of antipsychotic drugs: A systematic quantitative review of experimental studies , 2008, PAIN.

[41]  P. Chakraborty,et al.  Reasons for Drug Non-Compliance of Psychiatric Patients : A Centre Based Study , 2008 .

[42]  K. Elkington,et al.  HIV, syphilis, and hepatitis B and C prevalence among patients with mental illness: a review of the literature. , 2008, Cadernos de saude publica.

[43]  Betty Vreeland Treatment decisions in major mental illness: weighing the outcomes. , 2007, The Journal of clinical psychiatry.

[44]  J. Suvisaari,et al.  Visual impairment in persons with psychotic disorder , 2007, Social Psychiatry and Psychiatric Epidemiology.

[45]  S. Kisely,et al.  Inequitable access for mentally ill patients to some medically necessary procedures , 2007, Canadian Medical Association Journal.

[46]  A. Roalfe,et al.  Physical health care of patients with schizophrenia in primary care: a comparative study. , 2006, Family Practice.

[47]  J. Lieberman,et al.  Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline , 2006, Schizophrenia Research.

[48]  Alan S. Brown,et al.  Prenatal infection as a risk factor for schizophrenia. , 2006, Schizophrenia bulletin.

[49]  J. Schiffman,et al.  Premorbid childhood ocular alignment abnormalities and adult schizophrenia-spectrum disorder , 2006, Schizophrenia Research.

[50]  T. Mcneil,et al.  A prospective study of offspring of women with psychosis: visual dysfunction in early childhood predicts schizophrenia‐spectrum disorders in adulthood , 2005, Acta psychiatrica Scandinavica.

[51]  S. Khan,et al.  A study of reasons of non-compliance to psychiatric treatment. , 2005, Journal of Ayub Medical College, Abbottabad : JAMC.

[52]  R. N. L. Chafetz,et al.  The Poor General Health of the Severely Mentally Ill: Impact of Schizophrenic Diagnosis , 2005, Community Mental Health Journal.

[53]  E. Chipps,et al.  Use of general medical services among Medicaid patients with severe and persistent mental illness. , 2005, Psychiatric services.

[54]  L. Dixon,et al.  Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. , 2004, The American journal of psychiatry.

[55]  F. Dickerson,et al.  Comorbidity of Medical Illnesses Among Adults With Serious Mental Illness Who Are Receiving Community Psychiatric Services , 2004, The Journal of nervous and mental disease.

[56]  D. C. Taylor Schizophrenias and epilepsies: why? when? how? , 2003, Epilepsy & Behavior.

[57]  I. Nazareth,et al.  Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice , 2003, BMJ : British Medical Journal.

[58]  L. Niskanen,et al.  Metabolic syndrome in patients with schizophrenia. , 2003, The Journal of clinical psychiatry.

[59]  C. Pantelis,et al.  Medical comorbidity in schizophrenia , 2003, The Medical journal of Australia.

[60]  E. Yano,et al.  Use of general medical services by VA patients with psychiatric disorders. , 2002, Psychiatric services.

[61]  F. Dickerson,et al.  Health behaviors and health status of older women with schizophrenia. , 2002, Psychiatric services.

[62]  M. Phelan,et al.  Physical health of people with severe mental illness , 2001, BMJ : British Medical Journal.

[63]  S Woolhandler,et al.  Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.

[64]  W. Fenton Prevalence of spontaneous dyskinesia in schizophrenia. , 2000, The Journal of clinical psychiatry.

[65]  L. Dixon,et al.  Prevalence and correlates of diabetes in national schizophrenia samples. , 2000, Schizophrenia bulletin.

[66]  L. Goldman Medical illness in patients with schizophrenia. , 1999, The Journal of clinical psychiatry.

[67]  J. Nurnberger,et al.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.

[68]  E. Leskowitz Strabismus and schizophrenia. , 1984, The American journal of psychiatry.